Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dilapan vs Misoprostol for Cervical Ripening
NCT03670836Phase 4Completed
- Sponsor
- Columbia University
- Start
- Nov 2018
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Columbia University. Primary endpoint: Number of Women Achieving Vaginal Delivery Within 36 Hours After Initiation of Cervical Ripening. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT03670836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03670836.